Admission neutrophil-lymphocyte ratio predicts 90 day outcome after endovascular stroke therapy
about
The Predictive Role of Inflammatory Biomarkers in Atrial Fibrillation as Seen through Neutrophil-Lymphocyte Ratio MirrorThe role of inflammation in cardiovascular diseases: the predictive value of neutrophil-lymphocyte ratio as a marker in peripheral arterial diseaseHigher neutrophil counts before thrombolysis for cerebral ischemia predict worse outcomes.Gene expression profiling in stroke: relevance of blood-brain interaction.The Role of Arginase 1 in Post-Stroke Immunosuppression and Ischemic Stroke Severity.Dynamic change of neutrophil to lymphocyte ratio and hemorrhagic transformation after thrombolysis in stroke.Neutrophil-lymphocyte ratio as predictor of mortality and morbidity in cardiovascular surgery: a systematic review.Atrial Fibrillation is Strongly Associated With the Neutrophil to Lymphocyte Ratio in Acute Ischemic Stroke Patients: A Retrospective Study.Neutrophil-To-Lymphocyte Ratio Predicts 3-Month Outcome of Acute Ischemic Stroke.Evaluation of inflammatory cell biomarkers in chronic venous insufficiency.Monocyte-lymphocyte cross-communication via soluble CD163 directly links innate immune system activation and adaptive immune system suppression following ischemic stroke.Prognostic role of neutrophil-lymphocyte ratio in patients with acute ischemic stroke.Prognostic role of neutrophil lymphocyte ratio in patients with spontaneous intracerebral hemorrhage.The use of neutrophil to lymphocyte ratio as a predictor for clinical outcomes in spontaneous intracerebral hemorrhage.Admission neutrophil count and neutrophil to lymphocyte ratio predict 90-day outcome in intracerebral hemorrhage.Paradigm Shift to Neuroimmunomodulation for Translational Neuroprotection in Stroke.
P2860
Q26742118-86E95B3B-07B9-42C7-B226-F1E04A844445Q26745592-F9D6DCB6-3ACF-49C7-8EB1-AE5DBB0AA9C1Q30671155-D1EE4E9D-258D-4139-B28C-EE5D533AAB32Q36474007-0609A91B-538C-4B21-8DDA-C91C7966E982Q36627451-4E0AD0EB-44A4-41AE-BFDA-46F110074D97Q37209587-A462F64F-1EDA-4B20-A659-951F1714EA21Q38381355-5AA3F365-8813-4825-86C5-C95845FDA95FQ38411287-A56CFCD0-EEF5-46D5-8466-CD317CE3C40EQ38970544-384C60E3-5158-445E-B99F-9F6CC139AF39Q39221429-C9FF43D3-686C-4452-8367-24D7581F0930Q42374943-126A60D1-6D3D-468D-AB84-CC552B735C0DQ47109302-D6022E08-DA80-4015-ADB9-60FBB5E46823Q47110270-15039C0F-59CC-4F5A-886B-690F0954A4E5Q47152782-1A6A3EA3-D700-4427-B2F6-50B84CF4A2F0Q48406292-B252A9D2-9715-4878-BB44-8639799DBA59Q52564678-2E6E5BC2-43BC-4EEA-A20E-BB1F7CE8C1F5
P2860
Admission neutrophil-lymphocyte ratio predicts 90 day outcome after endovascular stroke therapy
description
2013 nî lūn-bûn
@nan
2013 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Admission neutrophil-lymphocyt ...... er endovascular stroke therapy
@ast
Admission neutrophil-lymphocyt ...... er endovascular stroke therapy
@en
type
label
Admission neutrophil-lymphocyt ...... er endovascular stroke therapy
@ast
Admission neutrophil-lymphocyt ...... er endovascular stroke therapy
@en
prefLabel
Admission neutrophil-lymphocyt ...... er endovascular stroke therapy
@ast
Admission neutrophil-lymphocyt ...... er endovascular stroke therapy
@en
P2093
P2860
P1476
Admission neutrophil-lymphocyt ...... er endovascular stroke therapy
@en
P2093
Ansaar Rai
Chauncey Spears
Christopher Cummings
Jeffrey Carpenter
Jennifer Domico
Kyle R Stinehart
Reyna L VanGilder
Stacey Culp
Steven D Brooks
Taura L Barr
P2860
P304
P356
10.1136/NEURINTSURG-2013-010780
P577
2013-10-11T00:00:00Z